📢 RedChip Unveils RedChat: AI-Powered Chatbot for Small-Cap Stock Insights 🔍 Revolutionizing Small-Cap Research @RedChip has launched RedChat, an advanced AI chatbot designed to provide investors with instant, data-driven insights into 2,000+ small-cap and microcap stocks. Leveraging SEC filings, press releases, and corporate disclosures, RedChat simplifies stock research—delivering precise, real-time answers in seconds. 💡 Why Investors Should Pay Attention: ✅ Instant Access to Key Metrics – Financials, partnerships, and strategic updates at your fingertips. ✅ Data-Backed Insights – Powered by AI, with responses sourced directly from official filings. ✅ Time-Saving Research Tool – No more sifting through lengthy reports—just ask and get answers. 🚀 RedChat is now available for free at #SmallCapStocks #AI #StockResearch #Investing #MicroCap #RedChat #FinancialNews $SMCI $MSTR $SOUN $MARA $IONQ $RIOT $AUR $JOBY $SMR $HIMS $RCAT $AENT $NXL $UMAC $GRRR $ASPI $NVA $MOB $MLSS

📢 60 Degrees Pharmaceuticals $SXTP Secures FDA Clearance to Ensure Continuous Malaria Prevention Supply in the U.S. 💊 Proactive Expansion: To prevent any near-term supply disruptions of its U.S.-approved malaria prophylaxis ARAKODA®, $SXTP has received FDA clearance to import KODATEF® from Australia as a precautionary measure. 💡 Why This Matters for Investors: ✅ Growing Demand – U.S. adoption of ARAKODA® is rising, driving expansion efforts. ✅ Regulatory Green Light – @FDA's non-objection signals confidence in $SXTP's approach. ✅ Strategic Execution – A five-month supply import ensures uninterrupted availability as manufacturing scales up. 📄 Read the full announcement: $SXTP #RedChip #RedChat #60P #SXTP #PharmaStocks #MalariaPrevention #BiotechInvesting #HealthcareInnovation #FinancialNews

🚨 Creative Medical Technology $CELZ: Positive One-Year Results for AlloStem™ in Type 2 Diabetes 🚨 📊 Key Findings: ✅ 80% efficacy in reducing insulin dependency & stabilizing HbA1c levels ✅ No serious adverse effects reported ✅ Supports ongoing FDA-cleared trial for Type 1 Diabetes 🔬 Why This Matters for Investors: 📈 Huge Market Opportunity – Over 38M Americans diagnosed with diabetes, with late-stage Type 2 cases often requiring insulin 🧪 Pipeline Expansion – CELZ-201 could be a breakthrough in regenerative medicine for diabetes 💡 Strategic Growth – Strengthens $CELZ's position in biotech innovation 📄 Read More: $CELZ @CMTH_Inc #RedChip #CreativeMedical #BiotechNews #DiabetesTreatment #HealthcareInnovation #Investing #RegenerativeMedicine #CELZ

🚀 The collectibles market is heating up, and while $FNKO remains a leader, a new player is making waves. $AENT just acquired Handmade by Robots, a unique vinyl collectibles brand featuring DC Comics, Harry Potter, Stranger Things & more. 💡 But here’s the difference — $AENT isn’t just a collectibles company; it’s a global distribution powerhouse. With direct access to Walmart, Target, Amazon & 35,000+ storefronts, Handmade by Robots is positioned for massive growth. Could this be Funko 2.0? 👀 Don’t miss out. 🔗 Learn more at $AENT $FNKO #RedChip #AllianceEntertainment #Stocks #Investing #FNKO #AENT #GrowthStocks

📊 ConnectM $CNTM Reports Triple-Digit Growth in 2024 Impact Scorecard $CNTM's 2024 Impact Scorecard showcases significant gains in electrification and sustainability: ⚡ 95.5 GWh of Electrification (+331% YoY) – Equivalent to powering 35,000 homes per day 🌿 73,506 Metric Tons of CO2 Displaced (+391% YoY) – Comparable to the CO2 absorbed by 3.4M trees annually ⛽ 6.7M Gallons of Fossil Fuel Displaced (+343% YoY) – Equal to driving around the world 7,000 times 🚀 Why This Matters: This substantial growth highlights ConnectM’s AI-driven Energy Intelligence Network’s ability to accelerate the electrification economy, reduce emissions, and drive sustainable energy adoption. 🔗 $CNTM #RedChip #ConnectM #CNTM #Electrification #Sustainability #GreenEnergy #Investing #ClimateTech

📢 $MMA: Transforming the $18.6B Martial Arts Industry with a Fully Integrated Community & Commerce Platform is set to revolutionize martial arts with the first-ever all-in-one digital platform, unifying fans, fighters, gyms, and brands into a single monetized ecosystem. Currently in beta, the official launch in Q2 2025 will reshape engagement and commerce for the sport’s 640M global fans. 💡 Why It Matters for Investors: ✅ Massive Market Opportunity: $18.6B U.S. martial arts industry with millions of active participants. ✅ Diverse Revenue Streams: Subscriptions, transaction fees, advertising, and sponsorships. ✅ Rapid Scaling Potential: 530K+ existing user profiles, 18K+ published gyms, and backing from high-profile investors with 60M+ social media reach. aims to be the digital hub for martial arts—modernizing fan engagement and unlocking new revenue pathways. 🔗 Read more here: @trainalta $MMA #RedChip #MMAInc #MMA #SportsTech #Investing #CombatSports #GrowthStock #FinancialNews

🚨 Nexalin Technology $NXL Appointed Industry Co-Chair of National TBI Registry Coalition @NexalinTech strengthens its leadership in brain health innovation by joining the National Traumatic Brain Injury Registry Coalition @TBIRegistryCo as Industry Co-Chair. This key role enhances Nexalin’s advocacy and research efforts, particularly in collaboration with policymakers in Washington, D.C. 💡 Why This Matters for Investors: ✅ Growing Market: Federal spending on TBI care is set to rise, opening significant opportunities. ✅ Research Expansion: Nexalin collaborates with @UCSDHealth and the @DeptVetAffairs to develop breakthrough TBI treatments for veterans. ✅ Policy Influence: Direct engagement with Congress and federal agencies to shape TBI healthcare initiatives. 📢 Stay tuned for further updates on Nexalin’s expanding role in the TBI sector. 🔗 $NXL #RedChip #Nexalin #NXL #Neurotech #HealthcareInnovation #TBI #Investing #BrainHealth #VeteransCare

📢 Gorilla Technology $GRRR Strengthens Shareholder Value with ATM Program Closure @GorillaTechGrp has officially closed its At-The-Market (ATM) program, reinforcing its commitment to protecting shareholder value and eliminating dilution concerns. This move follows the company’s share buyback initiative, emphasizing financial strength and long-term growth confidence. 💡 Why This Matters for Investors: ✅ No Further Dilution Risk from ATM: $GRRR stands by its commitment to shareholders. ✅ Financial Confidence: Strong revenue visibility and strategic execution. ✅ Long-Term Growth Focus: Prioritizing shareholder returns over new stock issuance. 📣 "We made a commitment to our shareholders that we would not dilute, and we are standing by that promise." - Jay Chandan, Chairman & CEO 🔗 $GRRR #RedChip #GorillaTech #GRRR #InvestorValue #ShareholderCommitment #TechStocks #FinancialNews

📢 Greenwich LifeSciences $GLSI Updates FLAMINGO-01 Phase III Trial with Open Label HLA Data Preliminary findings from analyzing open-label HLA data from its Phase III trial reveal that 46% of screened patients carry at least one HLA-A*02 allele, aligning with expectations and supporting the study's sample size estimates. 🔬 Why This Matters to Investors: ✅ Expanded Patient Insights: The open-label arm, now increased to 250 patients, may provide critical efficacy and immune response data in non-HLA-A*02 populations. ✅ Enhanced Trial Design: The ability to assess various HLA-A combinations strengthens GLSI-100’s commercial potential across diverse populations. ✅ Strategic Market Implications: Understanding HLA prevalence by race and ethnicity could inform commercialization strategies in key global markets. @GreenwichLS continues to advance GLSI-100 as a potential breakthrough in preventing breast cancer recurrences. Stay tuned for further updates as the trial progresses. 🔗 $GLSI #RedChip #GLSI #BiotechStocks #ClinicalTrials #BreastCancer #HER2 #Investing

📢 Enlivex Therapeutics $ENLV D. Boral Capital Reiterates Buy Rating & $13 Price Target @dboralcapital reaffirms its confidence in @EnlivexT $ENLV, citing the potential of its breakthrough immunotherapy platform, Allocetra™. 🔬 Key Takeaways for Investors: ✅ Game-Changing Science – Allocetra™ reprograms macrophages to restore immune balance, targeting critical unmet needs in sepsis, osteoarthritis, and inflammatory diseases. ✅ Multi-Billion-Dollar Market – Addressing $9B+ osteoarthritis and $33B+ sepsis markets, both with limited treatment options. ✅ Strong Momentum – Backed by a proven leadership team, a cash runway through 2026, and advancing clinical trials. Find out why D Boral thinks $ENLV is an undervalued biotech gem 📈 🔗 Read the Full Report: $ENLV #RedChip #Enlivex #BiotechStocks #Immunotherapy #ClinicalTrials #ENLV #Investing #HealthcareInnovation

📢 Missed the @CalidiBio Investor Webinar? Watch the Replay Now! 🚀 On Wednesday, $CLDI shared key updates on its groundbreaking oncolytic virotherapies, financial strength, and upcoming milestones. 🔎 Key Takeaways: ✅ Advancing glioblastoma & solid tumor treatments with stem cell-based delivery platforms ✅ FDA-cleared Phase 1b/2 trial set to begin enrollment in Q1 2025 ✅ Positioned in a $13B+ market with strong financial backing 🔗 Watch here: @CIRMnews @NorthwesternU @cityofhope @TheLancet $CLDI #RedChip #CalidiBio #CLDI #InvestorWebinar #CancerResearch #Oncology #BiotechStocks #OncolyticVirotherapy #FinancialNews

🔐 $TENB beats Q4 expectations with 11% YoY revenue growth, hitting $235M+ as enterprise cybersecurity demand accelerates. But what if security goes beyond networks? Gorilla Technology $GRRR is redefining security on a global scale—leveraging AI-driven solutions to protect smart cities, critical infrastructure, and industrial IoT. 💡 222% revenue growth in H1 2024 💰 $93M project backlog + $2B pipeline 🌍 Expanding across APAC, Europe & MENA Cybersecurity isn’t just digital — $GRRR is securing the physical world too. 🚀​ Learn more at @GorillaTechGrp $GRRR #RedChip #GorillaTech #TENB #GRRR #Cybersecurity #AI #SmartCities #Investing

📢 Reminder: $MMA Investor Webinar Today at 5:00 PM EST! Don't miss your chance to hear directly from as they outline their vision for transforming the global martial arts industry through technology, community engagement, and scalable monetization strategies. 💡 Key Topics for Investors: ✅ Subscription-Driven Growth – Expanding high-margin revenue streams for gyms, coaches, and athletes. ✅ Market Expansion – Converting millions of MMA fans into active participants. ✅ BJJLink Integration – Strengthening s role as the sport’s digital hub. 📅 Time: 5:00 – 5:45 PM EST 🔗 Join Here: @trainalta $MMA #RedChip #MMAInc #MMA #Investing #MartialArts #FinancialNews #GrowthStocks

RT @GreenPowerBus: In case you missed the recent interview of @GreenPowerBus CEO Fraser Atkinson by @RedChip, it is available now on YouTub…

🚀 @VSee Health $VSEE Secures $2M Contract Renewal with Leading Hospital System The $2 million, two-year contract renewal with a top 50 IDN hospital system doubles the number of covered hospital beds and adds autonomous self-driving robot solutions for neurocritical care. 💡 Why This Matters for Investors: ✅ Validates @VSee’s Value: Expanded contract renewal shows buyers find value in $VSEE's solutions. ✅ AI & Robotics Integration: Real-time patient monitoring and AI-assisted workflows enhance efficiency. ✅ Industry Disruption: Pioneering telenursing solutions to address workforce shortages and improve hospital operations. 📢 “This renewal solidifies our commitment the effectiveness of our comprehensive digital health stack.” – Imo Aisiku, M.D., Co-CEO 🔗 Read the full announcement: $VSEE #RedChip #VSEE #DigitalHealth #Telehealth #AI #HealthcareInnovation #Investing

🚀 $MMA Reports Record 200% YoY Growth in Warrior Training Program Sales! is on track to achieve $0.75M in Q1 gross sales for its Warrior Training Program. This 200% surge highlights s ability to convert the massive 640M-strong MMA fanbase into active martial arts participants—boosting revenue for partner gyms worldwide. 🔥 Why This Matters to Investors: ✅ Strong Revenue Growth: Highest-grossing quarter in program history, validating the scalable business model. ✅ Expanding Gym Network: 802 active partner gyms, bolstered by recent acquisition. ✅ Massive Market Potential: Growing global demand for MMA training experiences. is positioned to dominate the combat sports participation space, transforming fan engagement into sustainable revenue. 📄 Read the full announcement: @altaglobalgroup $MMA #RedChip #MMAInc #MMA #CombatSports #Investing #SportsTech #SmallCapStocks

📢 Trinity Biotech $TRIB: First-Day Accuracy Breakthrough in CGM Trial @TrinityBiotech reported a landmark 35% improvement in first-day accuracy for its next-gen continuous glucose monitoring (CGM) system, addressing a key industry challenge. 💡 Why Investors Should Take Note: ✅ Addresses Key User Pain Point: Inconsistent glucose readings on the first day of wear often lead to user frustration and safety concerns. ✅ Market Expansion Potential: Modular, affordable CGM design targets wider adoption among diabetes patients and health-conscious users. ✅ Regulatory Milestones Ahead: EU regulatory submission planned for 2025, FDA filing in 2026. 🚀 With the global CGM market projected to exceed $15B by 2028, could $TRIB’s latest breakthrough be a game-changer for diabetes care? 🔗 $TRIB #RedChip #TrinityBio #DiabetesTech #FinancialNews #CGM #TRIB #HealthInnovation #Investing

👂🧏‍♂️

🚀 Creative Medical Technology $CELZ Expands AI-Powered iPSCelz Development in Diabetes Treatment! $CELZ has strengthened its collaboration with @GreenstoneBio, integrating AI and multi-gene editing to enhance its hypoimmune induced pluripotent stem cell (iPSC) platform. 💡 Why Investors Should Take Note: ✅ AI-Driven Innovation – Accelerating drug discovery to enhance insulin secretion in iPSC-derived pancreatic islet cells. ✅ Reduced R&D Time – AI-guided development could cut research timelines by 50% and save millions in costs. ✅ Overcoming Immune Barriers – Advancements in hypoimmune iPSC tech could eliminate the need for immunosuppression, a key challenge in regenerative medicine. As $CELZ advances cutting-edge cell-based therapies, this collaboration underscores its leadership in next-gen diabetes and regenerative treatments. 📄 Read the Full Announcement Here: $CELZ #RedChip #CELZ #BiotechStocks #RegenerativeMedicine #AIinHealthcare #DiabetesTreatment #iPSCelz #Investing